Thirty percent of the global population have too much fat in their liver. The big question is: are they really sick when most will not end up with liver disease? This episode discusses: How should they be assessed and by whom?What does this mean to healthcare systems?Are there downsides to systematic screening?Faculty Aleksander Krag (Moderator)Alina Allen (Faculty)Manal El-Sayed (Faculty)Ian Rowe (FacultyRelated episode EASL Studio Live from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclatureAll EASL Studio Podcasts are available on EASL Campus.